Neuronetics Company

Neuronetics develops non-invasive therapies for psychiatric and neurological disorders.
Technology: Neuromodulation
Industry: Biotechnology, Health Care, Medical Device, Therapeutics
Headquarters: Malvern, Pennsylvania, United States
Founded Date: 2003
Employees Number: 101-250
Funding Status: IPO
Investors Number: 15
Total Funding: 248400000
Estimated Revenue: $10M to $50M
Last Funding Date: 2021
Last Funding Type: Post-IPO Equity

Visit Website
Register and Claim Ownership